SIRT1
Gene Ontology Biological Process
- DNA repair [TAS]
- DNA replication [TAS]
- DNA synthesis involved in DNA repair [ISS]
- angiogenesis [IDA]
- cell aging [TAS]
- cellular glucose homeostasis [ISS]
- cellular response to DNA damage stimulus [IDA]
- cellular response to hydrogen peroxide [IDA]
- cellular response to hypoxia [IMP]
- cellular response to ionizing radiation [ISS]
- cellular response to starvation [ISS]
- cellular response to tumor necrosis factor [IDA]
- cellular triglyceride homeostasis [ISS]
- cholesterol homeostasis [ISS]
- chromatin organization [IMP]
- chromatin silencing [TAS]
- chromatin silencing at rDNA [IDA]
- circadian regulation of gene expression [IMP, ISS]
- establishment of chromatin silencing [IDA]
- fatty acid homeostasis [ISS]
- histone H3 deacetylation [IDA, IMP]
- histone H3-K9 modification [ISS]
- histone deacetylation [IDA]
- intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [IMP]
- maintenance of chromatin silencing [IMP]
- methylation-dependent chromatin silencing [TAS]
- negative regulation of DNA damage response, signal transduction by p53 class mediator [IDA]
- negative regulation of I-kappaB kinase/NF-kappaB signaling [IDA]
- negative regulation of NF-kappaB transcription factor activity [IDA]
- negative regulation of TOR signaling [IMP]
- negative regulation of androgen receptor signaling pathway [IMP]
- negative regulation of apoptotic process [IMP]
- negative regulation of cAMP-dependent protein kinase activity [IDA]
- negative regulation of cell growth [IMP]
- negative regulation of cellular response to testosterone stimulus [IMP]
- negative regulation of cellular senescence [IDA]
- negative regulation of fat cell differentiation [ISS]
- negative regulation of helicase activity [IDA]
- negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [ISS]
- negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [IMP]
- negative regulation of peptidyl-lysine acetylation [IDA]
- negative regulation of phosphorylation [IMP]
- negative regulation of prostaglandin biosynthetic process [ISS]
- negative regulation of protein kinase B signaling [IMP]
- negative regulation of sequence-specific DNA binding transcription factor activity [IDA, IMP]
- negative regulation of transcription from RNA polymerase II promoter [IDA, IMP]
- negative regulation of transcription, DNA-templated [IDA]
- negative regulation of transforming growth factor beta receptor signaling pathway [ISS]
- peptidyl-lysine acetylation [IMP]
- peptidyl-lysine deacetylation [IDA]
- positive regulation of DNA repair [IMP]
- positive regulation of MHC class II biosynthetic process [IDA]
- positive regulation of adaptive immune response [IDA]
- positive regulation of apoptotic process [IDA, IMP]
- positive regulation of cAMP-dependent protein kinase activity [IMP]
- positive regulation of cell proliferation [IMP]
- positive regulation of cellular senescence [IDA]
- positive regulation of cholesterol efflux [ISS]
- positive regulation of chromatin silencing [IMP]
- positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [IMP]
- positive regulation of histone H3-K9 methylation [IMP]
- positive regulation of insulin receptor signaling pathway [IDA]
- positive regulation of macroautophagy [IDA]
- positive regulation of macrophage apoptotic process [ISS]
- positive regulation of protein phosphorylation [ISS]
- positive regulation of transcription from RNA polymerase II promoter [IDA]
- proteasome-mediated ubiquitin-dependent protein catabolic process [IMP]
- protein ADP-ribosylation [TAS]
- protein deacetylation [IDA, IMP]
- protein destabilization [ISS]
- protein ubiquitination [IDA]
- pyrimidine dimer repair by nucleotide-excision repair [IMP]
- regulation of bile acid biosynthetic process [ISS]
- regulation of cell proliferation [IMP]
- regulation of endodeoxyribonuclease activity [IMP]
- regulation of glucose metabolic process [ISS]
- regulation of mitotic cell cycle [IDA]
- regulation of peroxisome proliferator activated receptor signaling pathway [ISS]
- regulation of protein import into nucleus, translocation [IMP]
- regulation of smooth muscle cell apoptotic process [ISS]
- response to endoplasmic reticulum stress [ISS]
- response to hydrogen peroxide [IDA]
- response to insulin [ISS]
- response to oxidative stress [IDA]
- single strand break repair [IMP]
- triglyceride mobilization [ISS]
- white fat cell differentiation [ISS]
Gene Ontology Molecular Function- HLH domain binding [IPI]
- NAD+ ADP-ribosyltransferase activity [TAS]
- NAD-dependent histone deacetylase activity [IDA]
- NAD-dependent histone deacetylase activity (H3-K9 specific) [ISS]
- NAD-dependent protein deacetylase activity [IDA, IMP]
- bHLH transcription factor binding [IPI]
- deacetylase activity [IDA]
- enzyme binding [IPI]
- histone binding [IPI]
- histone deacetylase activity [IDA]
- identical protein binding [IPI]
- keratin filament binding [IPI]
- mitogen-activated protein kinase binding [IPI]
- p53 binding [IPI]
- protein C-terminus binding [IPI]
- protein binding [IPI]
- protein deacetylase activity [IDA]
- transcription corepressor activity [IDA, ISS]
- transcription factor binding [IPI]
- HLH domain binding [IPI]
- NAD+ ADP-ribosyltransferase activity [TAS]
- NAD-dependent histone deacetylase activity [IDA]
- NAD-dependent histone deacetylase activity (H3-K9 specific) [ISS]
- NAD-dependent protein deacetylase activity [IDA, IMP]
- bHLH transcription factor binding [IPI]
- deacetylase activity [IDA]
- enzyme binding [IPI]
- histone binding [IPI]
- histone deacetylase activity [IDA]
- identical protein binding [IPI]
- keratin filament binding [IPI]
- mitogen-activated protein kinase binding [IPI]
- p53 binding [IPI]
- protein C-terminus binding [IPI]
- protein binding [IPI]
- protein deacetylase activity [IDA]
- transcription corepressor activity [IDA, ISS]
- transcription factor binding [IPI]
Gene Ontology Cellular Component
- ESC/E(Z) complex [IDA]
- PML body [IDA]
- chromatin silencing complex [IDA]
- cytoplasm [IDA]
- mitochondrion [IDA]
- nuclear chromatin [IDA]
- nuclear envelope [IDA]
- nuclear euchromatin [IDA]
- nuclear heterochromatin [IDA]
- nuclear inner membrane [IDA]
- nucleolus [IDA]
- nucleoplasm [IDA]
- nucleus [IDA]
- rDNA heterochromatin [IDA]
SUMO2
Gene Ontology Biological Process
Gene Ontology Molecular Function
Biochemical Activity (Deacetylation)
An interaction is inferred from the biochemical effect of one protein upon another, for example, GTP-GDP exchange activity or phosphorylation of a substrate by a kinase. The bait protein executes the activity on the substrate hit protein. A Modification value is recorded for interactions of this type with the possible values Phosphorylation, Ubiquitination, Sumoylation, Dephosphorylation, Methylation, Prenylation, Acetylation, Deubiquitination, Proteolytic Processing, Glucosylation, Nedd(Rub1)ylation, Deacetylation, No Modification, Demethylation.
Publication
Acetylation of SUMO2 at lysine 11 favors the formation of non-canonical SUMO chains.
Post-translational modifications by ubiquitin-related SUMO modifiers regulate cellular signaling networks and protein homeostasis. While SUMO1 is mainly conjugated to proteins as a monomer, SUMO2/3 can form polymeric chains. Poly-SUMOylation is best understood in the SUMO-targeted ubiquitin ligase (StUbL) pathway, where chains prime proteins for subsequent ubiquitylation by StUbLs. SUMO chains typically form in response to genotoxic or proteotoxic stress and ... [more]
Throughput
- Low Throughput
Additional Notes
- in vitro deacetylation with SIRT1 as desumoylating enzyme and previously acetylated SUMO2 as substrate
Curated By
- BioGRID